Co-Diagnostics, Inc.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Salt Lake City, UT
CODX chart
What traders are saying about $CODX
Latest postsCo-Diagnostics, Inc. news
- Healthineers Insiders Line Up Tax-Driven Share Sales as Buyback Rolls On
ad-hoc-news.de ·
- Molecular-Diagnostics Reagents Market Forecast to 2035, Driven by Multiplex and Point-of-Care Assay Expansion
IndexBox ·
- 1,743,861 Equity Shares of Molbio Diagnostics Limited are subject to a Lock-Up Agreement Ending on 10-NOV-2026.
www.marketscreener.com ·
- LG Energy Solution Cuts Used-Battery Diagnostics From 7 Hours to 10 Minutes, Wins CES 2027 Innovation Award
BigGo Finance ·
- Stryker nominates Quest Diagnostics CEO to board
Investing.com ·
- Stryker nominates Quest Diagnostics CEO to board By Investing.com
Investing.com Canada ·
- The Latest in Surgical Raman Probes, Sepsis Diagnostics, and the Personalized Optical Twin
Spectroscopy Online ·
- Stryker nominates Quest Diagnostics CEO Jim Davis to its board
StreetInsider ·
- Lumos Diagnostics expands FebriDx rollout to an additional 97 WellStreet urgent care clinics
Proactive financial news ·
- Unitaid Invests $10.9m to Protect Essential Medicines, Diagnostics from Climate Change
Brand Icon Image ·
- Quest Diagnostics pays $13M to settle kickback allegations involving NY Giants tickets
Gothamist ·
- Quest Diagnostics CFO to speak at Jefferies Hea...
Pluang ·
Co-Diagnostics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $622,489 | $3.9M | $6.8M | $34.2M |
| Net income | -$47.0M | -$38.0M | -$35.3M | -$14.2M |
| Diluted EPS | $-35.25 | $-37.22 | $-1.20 | $-0.45 |
| Total assets (year end) | $24.7M | $63.6M | $95.3M | $123.1M |
| Cash and equivalents (year end) | $11.9M | $2.9M | $14.9M | $23.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Co-Diagnostics, Inc.
- Ticker
- CODX (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Salt Lake City, UT
- Incorporated in
- UT
- Fiscal year end
- December 31
- SEC CIK
- 1692415
Frequently asked questions
What exchange is Co-Diagnostics, Inc. listed on?
Co-Diagnostics, Inc. trades on the Nasdaq under the ticker symbol CODX.
What industry is Co-Diagnostics, Inc. in?
Co-Diagnostics, Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is Co-Diagnostics, Inc. headquartered?
Co-Diagnostics, Inc.'s business address on file with the SEC is in Salt Lake City, UT.
When does Co-Diagnostics, Inc.'s fiscal year end?
Co-Diagnostics, Inc.'s fiscal year ends on December 31.
How much revenue did Co-Diagnostics, Inc. report?
Co-Diagnostics, Inc. reported $622,489 in revenue for calendar year 2025, according to its SEC filings.